IL13 and atopic eczema: Several markers are employed to measure the severity of clinical symptoms of experimental atopic dermatitis including degree of scratching, pruritic skin lesion, and levels of pathogenic cytokines including IL-4, IL-5, IL-13 and IFN-γ.